Top 100 Contractors in PSC 65: Medical/Dental/Veterinary Equipment/Supplies, FY2021

Parent companies by net contract obligations Oct 1, 2020 – Sep 30, 2021 Code page on GovTribe

The top 10 won 85% of FY2021 PSC 65 contract dollars

Ranking facts

Contract obligations
$62,502,078,989 Net of deobligations, by contracts coded PSC 65 or a code under it
Contractors
4,157 Parent companies with an obligation
Largest contractor
Pfizer Inc. $23.1 billion, 36.3% of obligations
Data as of

Contract actions from FPDS (SAM.gov). How the rankings work · Download all 100 rows as CSV

Full ranking

Rank Contractor Net obligations Share Trend
1 $23,134,897,528
Rank history: #1 in FY2022, #4 in FY2023 and not on the FY2024–FY2025 lists; up 114 since FY2020.
2 $12,110,347,414
Rank history: #2 in FY2022, #1 in FY2023, #1 in FY2024 and #1 in FY2025; down 1 since FY2020.
3 $6,920,591,679
Rank history: #4 in FY2022 and not on the FY2023–FY2025 lists; unchanged since FY2020.
4 $5,565,148,165
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
5 $1,988,482,913
Rank history: #7 in FY2022, #3 in FY2023, #2 in FY2024 and #2 in FY2025; down 3 since FY2020.
6 $1,913,730,016
Rank history: #3 in FY2022 and not on the FY2023–FY2025 lists; new, not ranked in FY2020.
7
Merck & Co. Inc. 2 awardees, including Merck Sharp & Dohme LLC
$1,208,238,023
Rank history: #9 in FY2022, #53 in FY2023 and not on the FY2024–FY2025 lists; new, not ranked in FY2020.
8 $670,783,183
Rank history: #11 in FY2022, #5 in FY2023, #11 in FY2024 and not on the FY2025 list; up 3 since FY2020.
9 $502,115,933
Rank history: #13 in FY2022 and not on the FY2023–FY2025 lists; up 82 since FY2020.
10 $318,103,383
Rank history: #6 in FY2022, not on the FY2023 list, #35 in FY2024 and #57 in FY2025; up 7 since FY2020.
11 $261,759,751
Rank history: #16 in FY2022, #6 in FY2023, #6 in FY2024 and #3 in FY2025; up 9 since FY2020.
12 $256,699,640
Rank history: #31 in FY2022, #10 in FY2023 and not on the FY2024–FY2025 lists; up 6 since FY2020.
13 $241,157,345
Rank history: #17 in FY2022, #9 in FY2023, #9 in FY2024 and #5 in FY2025; up 13 since FY2020.
14 $228,368,602
Rank history: #18 in FY2022, #14 in FY2023, #12 in FY2024 and #8 in FY2025; up 5 since FY2020.
15 $220,974,969
Rank history: #85 in FY2022, #81 in FY2023 and not on the FY2024–FY2025 lists; up 68 since FY2020.
16 $212,896,055
Rank history: #8 in FY2022, #7 in FY2023 and not on the FY2024–FY2025 lists; up 35 since FY2020.
17 $211,814,036
Rank history: #20 in FY2022, #11 in FY2023, #7 in FY2024 and not on the FY2025 list; up 15 since FY2020.
18 $192,219,751
Rank history: #19 in FY2022, not on the FY2023 list, #8 in FY2024 and #10 in FY2025; up 21 since FY2020.
19 $160,492,513
Rank history: #10 in FY2022, #15 in FY2023, #68 in FY2024 and not on the FY2025 list; up 18 since FY2020.
20 $143,469,432
Rank history: #69 in FY2022, #37 in FY2023, #61 in FY2024 and #40 in FY2025; up 27 since FY2020.
21 $139,268,562
Rank history: not on the FY2022 list, #18 in FY2023, #50 in FY2024 and not on the FY2025 list; down 16 since FY2020.
22 $136,750,000
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
23 $133,755,597
Rank history: #21 in FY2022, #21 in FY2023, #16 in FY2024 and #16 in FY2025; down 13 since FY2020.
24 $126,000,000
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
25 $123,120,000
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
26 $114,920,191
Rank history: not on the FY2022–FY2025 lists; up 16 since FY2020.
27 $96,083,344
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
28 $95,497,600
Rank history: #15 in FY2022, #24 in FY2023, #10 in FY2024 and #14 in FY2025; up 12 since FY2020.
29 $94,814,751
Rank history: #41 in FY2022, #34 in FY2023, #44 in FY2024 and #44 in FY2025; up 35 since FY2020.
30 $94,662,235
Rank history: #78 in FY2022 and not on the FY2023–FY2025 lists; up 6 since FY2020.
31 $92,096,240
Rank history: #29 in FY2022 and not on the FY2023–FY2025 lists; down 23 since FY2020.
32 $84,788,192
Rank history: not on the FY2022–FY2025 lists; up 126 since FY2020.
33
Showa Glove Co. Through Showa Best Glove, Inc.
$81,284,996
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
34 $77,455,577
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
35
Iron Bow Technologies, LLC
$74,447,750
Rank history: not on the FY2022–FY2025 lists; up 3 since FY2020.
36 $70,868,832
Rank history: #30 in FY2022, #26 in FY2023, #22 in FY2024 and #20 in FY2025; up 30 since FY2020.
37 $69,300,000
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
38 $69,106,434
Rank history: #45 in FY2022, #47 in FY2023, #49 in FY2024 and #29 in FY2025; up 5 since FY2020.
39 $68,420,554
Rank history: #27 in FY2022, #54 in FY2023, #93 in FY2024 and #27 in FY2025; down 14 since FY2020.
40 $67,594,917
Rank history: #40 in FY2022, #39 in FY2023, #34 in FY2024 and #31 in FY2025; up 8 since FY2020.
41 $66,843,812
Rank history: #46 in FY2022, #31 in FY2023, #31 in FY2024 and #25 in FY2025; up 45 since FY2020.
42 $64,274,988
Rank history: #49 in FY2022, #35 in FY2023, #48 in FY2024 and #48 in FY2025; up 58 since FY2020.
43 $63,713,666
Rank history: #33 in FY2022, #27 in FY2023, #24 in FY2024 and #19 in FY2025; up 3 since FY2020.
44 $63,612,248
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
45 $62,750,143
Rank history: #23 in FY2022, #16 in FY2023, #13 in FY2024 and #13 in FY2025; up 7 since FY2020.
46 $61,365,221
Rank history: #52 in FY2022 and not on the FY2023–FY2025 lists; down 11 since FY2020.
47 $57,690,738
Rank history: #34 in FY2022, #28 in FY2023 and not on the FY2024–FY2025 lists; down 35 since FY2020.
48 $55,860,874
Rank history: not on the FY2022–FY2025 lists; up 56 since FY2020.
49 $54,921,477
Rank history: #39 in FY2022, #40 in FY2023, #25 in FY2024 and #67 in FY2025; up 29 since FY2020.
50 $54,372,927
Rank history: not on the FY2022–FY2025 lists; up 227 since FY2020.
51 $53,630,450
Rank history: #53 in FY2022, #36 in FY2023, #38 in FY2024 and #23 in FY2025; up 39 since FY2020.
52 $53,538,814
Rank history: not on the FY2022–FY2025 lists; up 79 since FY2020.
53 $52,049,393
Rank history: #50 in FY2022 and not on the FY2023–FY2025 lists; up 12 since FY2020.
54 $49,996,340
Rank history: #66 in FY2022 and not on the FY2023–FY2025 lists; new, not ranked in FY2020.
55 $49,054,134
Rank history: #56 in FY2022, #42 in FY2023, #47 in FY2024 and #49 in FY2025; up 18 since FY2020.
56 $48,104,000
Rank history: not on the FY2022–FY2025 lists; up 57 since FY2020.
57 $47,457,268
Rank history: #79 in FY2022, #41 in FY2023, not on the FY2024 list and #76 in FY2025; down 4 since FY2020.
58 $44,386,919
Rank history: #59 in FY2022, #43 in FY2023 and not on the FY2024–FY2025 lists; unchanged since FY2020.
59 $42,712,036
Rank history: not on the FY2022–FY2025 lists; down 44 since FY2020.
60 $42,501,157
Rank history: #64 in FY2022, #61 in FY2023 and not on the FY2024–FY2025 lists; up 64 since FY2020.
61 $40,938,063
Rank history: #12 in FY2022, #23 in FY2023, #79 in FY2024 and not on the FY2025 list; up 48 since FY2020.
62 $40,533,562
Rank history: #99 in FY2022, #52 in FY2023, #75 in FY2024 and #99 in FY2025; up 128 since FY2020.
63
Teva Pharmaceutical Industries Ltd. Through Teva Pharmaceuticals Usa, Inc.
$39,904,187
Rank history: #60 in FY2022, #50 in FY2023 and not on the FY2024–FY2025 lists; up 39 since FY2020.
64 $39,418,684
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
65 $39,261,396
Rank history: #67 in FY2022, #45 in FY2023, #70 in FY2024 and not on the FY2025 list; up 15 since FY2020.
66 $38,961,000
Rank history: not on the FY2022–FY2025 lists; down 5 since FY2020.
67 $36,883,922
Rank history: #68 in FY2022, #44 in FY2023, #40 in FY2024 and #33 in FY2025; up 70 since FY2020.
68 $35,998,392
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
69 $34,953,404
Rank history: not on the FY2022–FY2023 lists, #64 in FY2024 and not on the FY2025 list; new, not ranked in FY2020.
70 $34,490,806
Rank history: #93 in FY2022, #57 in FY2023 and not on the FY2024–FY2025 lists; up 89 since FY2020.
71
William Demants OG Hustru IDA Emilies (MILLAS) Fond - Kaldet 12 awardees, including Oticon, Inc., E3 Diagnostics, Inc. and Diagnostic Group LLC
$34,041,827
Rank history: #47 in FY2022, #29 in FY2023, #72 in FY2024 and not on the FY2025 list; up 36 since FY2020.
72 $33,902,266
Rank history: #35 in FY2022 and not on the FY2023–FY2025 lists; new, not ranked in FY2020.
73 $33,769,462
Rank history: #75 in FY2022, #46 in FY2023, #57 in FY2024 and #38 in FY2025; up 52 since FY2020.
74 $33,619,278
Rank history: #61 in FY2022, #65 in FY2023, #80 in FY2024 and not on the FY2025 list; up 22 since FY2020.
75 $31,687,733
Rank history: #28 in FY2022, #20 in FY2023, #15 in FY2024 and #12 in FY2025; up 128 since FY2020.
76 $31,618,151
Rank history: not on the FY2022 list, #48 in FY2023, #81 in FY2024 and not on the FY2025 list; down 48 since FY2020.
77 $30,481,013
Rank history: not on the FY2022 list, #51 in FY2023, #46 in FY2024 and #52 in FY2025; down 36 since FY2020.
78 $30,373,853
Rank history: #58 in FY2022, #19 in FY2023, #42 in FY2024 and not on the FY2025 list; new, not ranked in FY2020.
79 $29,999,588
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
80 $29,698,859
Rank history: #37 in FY2022, #89 in FY2023, #29 in FY2024 and #50 in FY2025; down 21 since FY2020.
81 $29,275,055
Rank history: #57 in FY2022, #69 in FY2023 and not on the FY2024–FY2025 lists; up 22 since FY2020.
82 $28,062,477
Rank history: #82 in FY2022, #63 in FY2023 and not on the FY2024–FY2025 lists; down 28 since FY2020.
83 $26,827,060
Rank history: not on the FY2022–FY2023 lists, #4 in FY2024 and #4 in FY2025; down 54 since FY2020.
84 $26,588,565
Rank history: #76 in FY2022, #30 in FY2023, #90 in FY2024 and not on the FY2025 list; up 36 since FY2020.
85 $25,644,319
Rank history: #62 in FY2022, #55 in FY2023 and not on the FY2024–FY2025 lists; down 15 since FY2020.
86 $24,683,448
Rank history: #97 in FY2022 and not on the FY2023–FY2025 lists; up 31 since FY2020.
87 $24,405,100
Rank history: #89 in FY2022, #82 in FY2023, not on the FY2024 list and #79 in FY2025; up 74 since FY2020.
88 $24,187,726
Rank history: #81 in FY2022, #83 in FY2023 and not on the FY2024–FY2025 lists; up 85 since FY2020.
89 $22,980,675
Rank history: #73 in FY2022, #91 in FY2023, #94 in FY2024 and not on the FY2025 list; up 23 since FY2020.
90 $22,707,717
Rank history: #63 in FY2022, #67 in FY2023 and not on the FY2024–FY2025 lists; up 21 since FY2020.
91 $22,505,987
Rank history: not on the FY2022–FY2025 lists; down 28 since FY2020.
92 $22,501,800
Rank history: not on the FY2022–FY2024 lists and #70 in FY2025; up 128 since FY2020.
93 $22,288,015
Rank history: #95 in FY2022, #75 in FY2023 and not on the FY2024–FY2025 lists; up 52 since FY2020.
94 $21,974,889
Rank history: #74 in FY2022, #56 in FY2023 and not on the FY2024–FY2025 lists; up 36 since FY2020.
95 $21,858,146
Rank history: not on the FY2022–FY2025 lists; up 385 since FY2020.
96 $21,271,706
Rank history: not on the FY2022 list, #17 in FY2023 and not on the FY2024–FY2025 lists; down 74 since FY2020.
97 $21,089,214
Rank history: #94 in FY2022, #84 in FY2023 and not on the FY2024–FY2025 lists; up 13 since FY2020.
98 $19,938,662
Rank history: #84 in FY2022, #97 in FY2023 and not on the FY2024–FY2025 lists; down 4 since FY2020.
99 $19,921,510
Rank history: not on the FY2022–FY2024 lists and #66 in FY2025; up 6 since FY2020.
100 $19,650,850
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
Show 75 more

100 of 4,157 contractors listed here. See the rest on GovTribe.

Rankings for the codes under PSC 65

Code Net obligations Largest contractor
6505 Drugs and Biologicals $54,731,983,817 Pfizer Inc.
6515 Medical and Surgical Instruments, Equipment, and Supplies $5,696,116,771 Cardinal Health, Inc.
6525 X-Ray Equipment and Supplies: Medical, Dental, Veterinary $864,697,094 Siemens Aktiengesellschaft
6550 In Vitro Diagnostic Substances, Reagents, Test Kits and Sets $597,888,712 Astrazeneca PLC
6530 Hospital Furniture, Equipment, Utensils, and Supplies $433,011,428 Beacon Point Associates LLC
6540 Ophthalmic Instruments, Equipment, and Supplies $70,463,374 PDS Consultants, Inc.
6520 Dental Instruments, Equipment, and Supplies $47,044,149 Katmai Health Services LLC
6545 Replenishable Field Medical Sets, Kits, and Outfits $32,651,860 Tribalco LLC
6532 Hospital and Surgical Clothing and Related Special Purpose Items $12,335,932 At Ease Sustainment LLC
6510 Surgical Dressing Materials $8,582,713 Stratatech Corporation
6509 Drugs and Biologicals, Veterinary Use $6,978,492 Boehringer Ingelheim Corporation

How this ranking works

  • Source: every contract action FPDS records (as published on SAM.gov) in the period, as GovTribe received it.
  • Amounts are net obligations: what was obligated, less what was deobligated. Shares are of $63.8 billion obligated before deobligations, so they never pass 100%.
  • Parent companies: each action counts under the ultimate parent its award record names, or under the awardee when it names none, so no dollar counts twice. Parents of the same name (Inc., LLC and the like aside) count as one company, since FPDS records a company's parent under more than one UEI over time. GovTribe corrects a few parents and names by hand; see the corrections.
  • Fiscal year 2021 ran Oct 1, 2020 – Sep 30, 2021. The Department of Defense reports its contract actions to FPDS about 90 days late, so a fiscal year is ranked once they're in, in February, and the list doesn't change after.
  • Rank changes compare with FY2020. "New" marks a company outside that period's top 500, and "Returned" one of those that was on an earlier fiscal year's list.
  • Rank lines show each company's rank on every fiscal year's list since FY2021, #1 at the top, on a scale that gives the top of the list more room. A dashed stretch spans years it wasn't on the list. The step from FY2020 takes the color of the rank change beside it.
  • Placeholder recipients FPDS uses when it names no company ("Miscellaneous Foreign Contractors" and the like) aren't ranked.

Quick answers

Who were the top 10 PSC 65 contractors in FY2021?

1. Pfizer Inc. ($23.1B), 2. Mckesson Corporation ($12.1B), 3. Modernatx Inc. ($6.92B), 4. Regeneron Pharmaceuticals Inc. ($5.57B), 5. Cencora, Inc. ($1.99B), 6. ELI Lilly and Company ($1.91B), 7. Merck & Co. Inc. ($1.21B), 8. Cardinal Health, Inc. ($671M), 9. Astrazeneca PLC ($502M), 10. Glaxosmithkline LLC ($318M).

On GovTribe

Research every contractor on this list

  • Every contract, task order and IDV they hold
  • Their subsidiaries, teammates and competitors
  • Open opportunities they're positioned for
  • Alerts when they win new work